Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity

Fumiyuki Yamasaki, Dongwei Zhang, Chandra Bartholomeusz, Tamotsu Sudo, Gabriel N. Hortobagyi, Kaoru Kurisu, Naoto T. Ueno

Research output: Contribution to journalArticlepeer-review

63 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science